13.3(top 1%)
Impact Factor
14.7(top 1%)
extended IF
144(top 2%)
H-Index
0
authors
1,769
papers
96,854
citations
0
citing journals
0
citing authors

Most Cited Articles of Pharmacology & Therapeutics in 2015

TitleYearCitations
Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases2015787
Targeting the TGFβ pathway for cancer therapy2015409
Glioblastoma multiforme: Pathogenesis and treatment2015351
ATM and ATR as therapeutic targets in cancer2015342
Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data2015273
Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders2015257
FAK signaling in human cancer as a target for therapeutics2015223
Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses2015221
Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy2015207
Epithelial-mesenchymal transition in human cancer: comprehensive reprogramming of metabolism, epigenetics, and differentiation2015196
Sp1 transcription factor: A long-standing target in cancer chemotherapy2015185
Structure and function of serotonin G protein-coupled receptors2015185
Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine2015182
Deubiquitinase inhibition as a cancer therapeutic strategy2015181
Cannabis and adolescent brain development2015170
Neuroprotection for ischaemic stroke: current status and challenges2015151
Cell-penetrating peptides transport therapeutics into cells2015151
Leukocyte integrins: role in leukocyte recruitment and as therapeutic targets in inflammatory disease2015149
Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer2015148
Targeting the Wnt pathway in human cancers: therapeutic targeting with a focus on OMP-54F282015147
Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection2015144
PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer2015140
Targeting histone lysine methylation in cancer2015136
The poly(I:C)-induced maternal immune activation model in preclinical neuropsychiatric drug discovery2015132
Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds2015126